The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
The Dualistic Model of Ovarian Carcinogenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
WHO classification of tumours of female reproductive organs
Kurman, R. J., Carcangiu, M. L., Herrington, C. S., & Young, R. H. (2014) · International Agency for Research on Cancer eBooks · Cited by 1,966
Self-citationARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712 · cited 2×
“Inactivating mutation of ARID1A, a tumor suppressor gene involved in switch/sucrose non-fermentable (SWI/SNF) chromatin remodeling, was detected in up to 50% of clear cell carcinomas and 30% of endometrioid carcinomas.(21,57,58) Moreover, mutation and loss of expression of this gene was found in the endometriotic epit…”
BackgroundSelf-citationWhole–genome characterization of chemoresistant ovarian cancer
Patch, A.-M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,569
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0196 · Cited by 1,467
Buys, S. S. (2011) · JAMA · doi:10.1001/jama.2011.766 · Cited by 1,323
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
Self-citationShih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
Self-citationKindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
Research works printed but not linked: 12
- Schmeler, 2010, Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary, Obstet Gynecol, 116, 269, 10.1097/AOG.0b013e3181e7961d · doi:10.1097/aog.0b013e3181e7961d
- Ardighieri, 2014, Shih IeM: Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants, J Pathol, 232, 16, 10.1002/path.4293 · doi:10.1002/path.4293
- Maniar, 2014, Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases, Am J Surg Pathol, 38, 743, 10.1097/PAS.0000000000000155 · doi:10.1097/pas.0000000000000155
- Silva, 1990, Ovarian carcinomas with transitional cell carcinoma pattern, Am J Clin Pathol, 93, 457, 10.1093/ajcp/93.4.457 · doi:10.1093/ajcp/93.4.457
- Ardighieri, 2014, Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants, J Pathol, 232, 16, 10.1002/path.4293 · doi:10.1002/path.4293
- Shappell, 2002, Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas, Am J Surg Pathol, 26, 1529, 10.1097/00000478-200212000-00001 · doi:10.1097/00000478-200212000-00001
- Cuatrecasas, 1997, K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases, Cancer, 79, 1581, 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T · doi:10.1002/(sici)1097-0142(19970415)79:8<1581::aid-cncr21>3.0.co;2-t
- Wang, 2015, Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin, J Pathol, 237, 146, 10.1002/path.4572 · doi:10.1002/path.4572
- Piek, 2001, Tubal ligation and risk of ovarian cancer, Lancet, 358, 844, 10.1016/S0140-6736(01)05992-X · doi:10.1016/s0140-6736(01)05992-x
- Gagner, 2005, Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma, Gynecol Oncol, 97, 219, 10.1016/j.ygyno.2004.11.053 · doi:10.1016/j.ygyno.2004.11.053
- Bijron, 2013, Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis, Am J Surg Pathol, 37, 1123, 10.1097/PAS.0b013e318282da7f · doi:10.1097/pas.0b013e318282da7f
- Wethington, 2013, Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC), Int J Gynecol Cancer, 23, 1603, 10.1097/IGC.0b013e3182a80ac8 · DOI
Cited by
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
High grade serous ovarian carcinomas originate in the fallopian tube
Labidi-Galy, S. I., Papp, E., Hallberg, D., Niknafs, N., Adleff, V., Noe, M., Bhattacharya, R., Novak, M., Jones, S., Phallen, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00962-1 · Cited by 759
Self-citationHigh-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z.-H., & Telleria, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040952 · Cited by 680
Cancer-associated mutations in endometriosis without cancer
Anglesio, M. S., Papadopoulos, N., Ayhan, A., Nazeran, T. M., Noë, M., Horlings, H. M., Lum, A., Jones, S., Senz, J., Seckin, T., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614814 · Cited by 628
Self-citationCA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 602
The Origin and Pathogenesis of Endometriosis
Wang, Y., Nicholes, K., & Shih, I.-M. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032654 · Cited by 455
Self-citationDisis, M. L., Taylor, M. H., Kelly, K., Beck, J. T., Gordon, M., Moore, K. M., Patel, M. R., Chaves, J., Park, H., Mita, A. C., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.6258 · Cited by 437
Hereditary breast and ovarian cancer: new genes in confined pathways
Nielsen, F. C., van Overeem Hansen, T., & Sørensen, C. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.72 · Cited by 367
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
Damia, G., & Broggini, M. (2019) · Cancers · doi:10.3390/cancers11010119 · Cited by 298
Kim, H., George, E., Ragland, R. L., Rafail, S., Zhang, R., Krepler, C., Morgan, M. A., Herlyn, M., Brown, E. J., & Simpkins, F. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2273 · Cited by 291
IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
Browning, L., Patel, M., Bring Horvath, E., Tawara, K., & Jorcyk, C. L. (2018) · Cancer Management and Research · doi:10.2147/cmar.s179189 · Cited by 286
Prat, J., D'Angelo, E., & Espinosa, I. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.06.018 · Cited by 275
Niu, N., Mercado-Uribe, I., & Liu, J. (2017) · Oncogene · doi:10.1038/onc.2017.72 · Cited by 265
The Origin of Ovarian Cancer Species and Precancerous Landscape
Shih, I.-M., Wang, Y., & Wang, T.-L. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.09.006 · Cited by 255
Self-citationMolecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
Rojas, V., Hirshfield, K., Ganesan, S., & Rodriguez-Rodriguez, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122113 · Cited by 254
Estrogen-progestins and progestins for the management of endometriosis
Vercellini, P., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E., & Bosari, S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.022 · Cited by 243
Medical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
The dualistic origin of human tumors
Liu, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.004 · Cited by 148
(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
The Endometriotic Tumor Microenvironment in Ovarian Cancer
Wendel, J. R. H., Wang, X., & Hawkins, S. M. (2018) · Cancers · doi:10.3390/cancers10080261 · Cited by 51
Huang, H., Hsu, C., Chu, S., Chen, P., Ding, D., Chang, M., & Chu, T. (2016) · The Journal of Pathology · doi:10.1002/path.4807 · Cited by 38
Management of endometriosis: Toward value-based, cost-effective, affordable care
Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.011 · Cited by 36
Heredia-Soto, V., Redondo, A., Berjón, A., Miguel-Martín, M., Díaz, E., Crespo, R., Hernández, A., Yébenes, L., Gallego, A., Feliu, J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25098 · Cited by 33
Funingana, I.-G., Reinius, M. A. V., Petrillo, A., Ang, J. E., & Brenton, J. D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.008 · Cited by 23
Chang, C. Y.-Y., Tseng, C.-C., Lai, M.-T., Chiang, A.-J., Lo, L.-C., Chen, C.-M., Yen, M.-J., Sun, L., Yang, L., Hwang, T., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0248168 · Cited by 20
“Therefore, endometriosis shares several characteristics of cancer such as cell migration, proliferation and anti-anoikis activity, even though endometriosis is usually considered to be a benign lesion [1,2].”
BackgroundMishra, B., Lawson, G. W., Ripperdan, R., Ortiz, L., & Luderer, U. (2018) · Radiation Research · doi:10.1667/rr15028.1 · Cited by 18
Metadata
- Authors
- Kurman, R. J., & Shih, I.-M.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 186
- Issue
- 4
- Pages
- 733-747
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W2305551225
- Cited by
- 923
- References
- 93
- FWCI
- 111.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1351 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.